Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Inventory (2016 - 2023)

Historic Change in Inventory for iBio (IBIO) over the last 6 years, with Q1 2023 value amounting to -$43000.0.

  • iBio's Change in Inventory fell 10331.28% to -$43000.0 in Q1 2023 from the same period last year, while for Jun 2023 it was $1.0 million, marking a year-over-year decrease of 7379.29%. This contributed to the annual value of $1.0 million for FY2023, which is 7379.29% down from last year.
  • iBio's Change in Inventory amounted to -$43000.0 in Q1 2023, which was down 10331.28% from -$79000.0 recorded in Q4 2022.
  • iBio's Change in Inventory's 5-year high stood at $1.4 million during Q4 2021, with a 5-year trough of -$639000.0 in Q1 2021.
  • Over the past 4 years, iBio's median Change in Inventory value was $228000.0 (recorded in 2020), while the average stood at $374181.8.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 114444.44% in 2021, then plummeted by 10564.69% in 2022.
  • Over the past 4 years, iBio's Change in Inventory (Quarter) stood at $228000.0 in 2020, then skyrocketed by 513.6% to $1.4 million in 2021, then plummeted by 105.65% to -$79000.0 in 2022, then skyrocketed by 45.57% to -$43000.0 in 2023.
  • Its last three reported values are -$43000.0 in Q1 2023, -$79000.0 for Q4 2022, and $1.1 million during Q3 2022.